Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Brittany L Bychkovsky; Min-Tzu Lo; Amal Yussuf; Carrie Horton; Parichehr Hemyari; Holly LaDuca; Judy E Garber; Rochelle Scheib; Huma Q Rana

doi:10.1007/s10549-023-06928-w

Correction to: Pathogenic variants among females with breast cancer and a non‑breast cancer reveal opportunities for cancer interception

Breast Cancer Res Treat. 2023 Jul;200(1):73. doi: 10.1007/s10549-023-06928-w.

Authors

Brittany L Bychkovsky^{1

2

3

4}, Min-Tzu Lo⁵, Amal Yussuf⁵, Carrie Horton⁵, Parichehr Hemyari⁵, Holly LaDuca⁵, Judy E Garber^{6

7

8

9}, Rochelle Scheib^{6

7

8

9}, Huma Q Rana^{6

7

8

9}

Affiliations

¹ Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA. Brittany_Bychkovsky@dfci.harvard.edu.
² Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu.
³ Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu.
⁴ Harvard Medical School, Boston, MA, USA. Brittany_Bychkovsky@dfci.harvard.edu.
⁵ Ambry Genetics, Aliso Viejo, CA, USA.
⁶ Department of Medical Oncology, Dana-Farber Cancer Institute, 450 Brookline Ave, Boston, MA, 02215, USA.
⁷ Breast Oncology Program, Dana-Farber Brigham Cancer Center, Boston, MA, USA.
⁸ Division of Cancer Genetics and Prevention, Dana-Farber Cancer Institute, Boston, MA, USA.
⁹ Harvard Medical School, Boston, MA, USA.

No abstract available

Publication types

Published Erratum